CTSO
Cytosorbents Corporation
NASDAQ · USHealthcareMedical - Devices
$0.38+5.58%
Price as of Jul 20, 2026
CTSO capital
Cytosorbents Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 8.64x
- Net debt / equity
- 6.45x
- Debt / assets
- 0.47x
- Debt / EBITDA
- -2.44x
- Net debt / EBITDA
- -1.82x
Liquidity & coverage
- Current ratio
- 1.09x
- Quick ratio
- 0.81x
- Cash ratio
- 0.30x
- Interest coverage
- -11.65x
- EBITDA / interest
- -6.77x
- Working capital
- $1.5M
Cash & dividend
- FCF / debt
- -0.54x
- Cash flow / debt
- -0.53x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.